Cargando…
Choosing the Right Tool for Genetic Engineering: Clinical Lessons from Chimeric Antigen Receptor-T Cells
T cell modification with genes that encode chimeric antigen receptors (CAR-T cells) has shown tremendous promise for the treatment of B cell malignancies. The successful translation of CAR-T cell therapy to other tumor types, including solid tumors, is the next big challenge. As the field advances f...
Autores principales: | Irving, Melita, Lanitis, Evripidis, Migliorini, Denis, Ivics, Zoltán, Guedan, Sonia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8697565/ https://www.ncbi.nlm.nih.gov/pubmed/34662233 http://dx.doi.org/10.1089/hum.2021.173 |
Ejemplares similares
-
Engineering and Design of Chimeric Antigen Receptors
por: Guedan, Sonia, et al.
Publicado: (2018) -
Targeting the tumor vasculature to enhance T cell activity
por: Lanitis, Evripidis, et al.
Publicado: (2015) -
Chimeric Antigen Receptor Immunotherapy for Solid Tumors: Choosing the Right Ingredients for the Perfect Recipe
por: Castiello, Luciano, et al.
Publicado: (2022) -
Optimized gene engineering of murine CAR-T cells reveals the beneficial effects of IL-15 coexpression
por: Lanitis, Evripidis, et al.
Publicado: (2020) -
Engineering Chimeric Antigen Receptor T-Cells for Racing in Solid Tumors: Don’t Forget the Fuel
por: Irving, Melita, et al.
Publicado: (2017)